Viewing Study NCT06180369


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2025-12-24 @ 10:51 PM
Study NCT ID: NCT06180369
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-12-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Clinical Efficacies of Different Agents in Molar-Incisor Hypomineralization
Sponsor: Marmara University
Organization:

Study Overview

Official Title: Evaluation of Clinical Efficacies of Different Agents in Molar-Incisor Hypomineralization-Affected Molars
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to assess the clinical effectiveness of GC Fuji Triage ® (GC America Inc., Alsip, Illinois) and BeutiSealant (Shofu, Kyoto, Japan) in children aged 8-13 with multiple molars affected by Molar-Incisor Hypomineralization (MIH). The comparison focuses on permanent first molars affected by MIH.
Detailed Description: The study targets children within the specified age range with MIH-affected molars, comparing the clinical outcomes of GC Fuji Triage and BeutiSealant. The assessment will provide valuable insights into the efficacy of these agents in managing severe hypomineralization, contributing to our understanding of effective treatment modalities for MIH.

The evaluation criteria include restoration success, prevention of further decay development, prevention of post-eruption breakdown, alleviation of tooth sensitivity, and measurement of life quality. These criteria will be compared with those of Resin Fissure Sealant.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: